首页> 美国卫生研究院文献>Heliyon >Development of new generation of vaccines for Brucella abortus
【2h】

Development of new generation of vaccines for Brucella abortus

机译:开发用于流产布鲁氏菌的新一代疫苗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Brucella abortus is a Gram-negative facultative and intracellular bacteria, it causes bovine brucellosis, a zoonotic disease that is responsible for considerable economic loss to owners of domesticated animals and can cause problems in otherwise healthy humans. There are a few available live attenuated vaccines for animal immunization against brucellosis; however, these have significant side effects and offer insufficient protective efficacy. Thus, the need for more research into the Molecular pathobiology and immunological properties of B. abortus that would lead to the development of better and safer vaccines. In this paper we have reviewed the main aspects of the pathology and the responsive immunological mechanisms, we have also covered current and new prospective vaccines against B. abortus.
机译:流产布鲁氏菌是革兰氏阴性兼性和细胞内细菌,它引起牛布鲁氏菌病,这是一种人畜共患疾病,对家养动物的所有人造成可观的经济损失,并可能给其他健康人带来问题。有几种可用的减毒活疫苗可用于动物免疫布鲁氏菌病。然而,这些具有显着的副作用并且提供不足的保护功效。因此,需要对流产双歧杆菌的分子病理学和免疫学特性进行更多研究,以开发出更好,更安全的疫苗。在本文中,我们回顾了病理学的主要方面和响应性免疫机制,我们还涵盖了针对流产双歧杆菌的当前和新型前瞻性疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号